Defined structure. Reproducible performance. Reliable supply.
Controlled liposomal systems produced for integration into partner formulations and finished products
GMPriority Pharma manufactures bulk liposomal systems for integration into partner formulations and finished products.
Produced within GMP-certified, FSSC ISO 22000-accredited UK facilities, these systems are developed and manufactured using defined processing parameters to support consistency, compatibility and scalable supply.
Bulk liposomal ingredients are supplied as controlled functional inputs, not generic ingredients.
Each ingredient is developed with defined structural and processing parameters to ensure predictable behaviour when integrated into downstream formulations and manufacturing environments.
This enables partners to work with liposomal systems that are:
Delivery is designed with manufacturing in mind.
GMPriority Pharma supplies both liquid and dry-format liposomal systems, designed to support different formulation and manufacturing requirements.
Bulk supply provides access to liposomal ingredient formats suitable for integration into:
Liquid Systems
Hydrated liposomal dispersions suitable for direct integration into liquid formulations or further processing.
Dry Systems
Solid-state liposomal formats produced through controlled drying processes, enabling:
Each format is defined by controlled composition, processing parameters and structural targets to ensure consistent behaviour across applications.
All bulk ingredient supplied by GMPriority Pharma are manufactured in-house within our GMP-accredited facilities
Defined liposomal processing protocols
Structured batch production
Controlled environmental conditions
Integrated, rigorous quality systems
Bulk liposomal systems are manufactured using strict processes aligned with formulation behaviour and production requirements.
Production is governed by structured process control, batch traceability and defined parameter ranges, supporting reproducible output across manufacturing cycles.
Bulk liposomal systems are supplied to support a range of partner models including:
This model provides flexibility for partners requiring controlled liposomal inputs with finished product manufacture or brand constraints.
Bulk liposomal systems are typically supplied where:
Formulation is defined but requires controlled liposomal input
Manufacturing is carried out by partner or third-party facilities
Ingredient-level consistency is critical to finished product performance
This model supports partners seeking to retain control of formulation or manufacturing while relying on GMPriority Pharma for delivery system production.
Controlled liposomal systems designed for integration, compatibility and long-term commercial supply.